香港股市 將收市,收市時間:5 小時 4 分鐘

Becton, Dickinson and Company (BDX)

NYSE - NYSE 延遲價格。貨幣為 USD。
加入追蹤清單
248.47-5.70 (-2.24%)
收市價: 04:00PM EST
248.47 0.00 (0.00%)
收市後: 04:16PM EST
全螢幕
交易股價資料並非來自所有市場
前收市價254.17
開市239.17
買盤0.00 x 900
賣出價0.00 x 900
今日波幅236.11 - 257.69
52 週波幅215.90 - 277.29
成交量3,033,954
平均成交量1,381,378
市值70.632B
Beta 值 (5 年,每月)0.58
市盈率 (最近 12 個月)46.18
每股盈利 (最近 12 個月)5.38
業績公佈日2023年2月02日
遠期股息及收益率3.64 (1.43%)
除息日2023年3月09日
1 年預測目標價270.92
  • Insider Monkey

    15 Largest Healthcare Companies by Market Cap

    In this article, we will be taking a look at the 15 largest healthcare companies by market cap. To skip our detailed analysis, you can go directly to see 5 largest healthcare companies by market cap. Competition should always be encouraged in the business world. After all, competition breeds innovation and innovation results in better […]

  • Insider Monkey

    Dividend Aristocrats List by Yield: Top 25 Stocks

    In this article, we discuss top 25 Dividend Aristocrats by yield. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read Dividend Aristocrats List by Yield: Top 10 Stocks. Investors are showing renewed interest in dividend stocks this year as the market plunges to new […]

  • Benzinga

    Becton Dickinson's FY23 Guidance Trails Wall Street View Reflecting Foreign Currency Impact

    Becton Dickinson and Co (NYSE: BDX) reported Q4 FY22 revenues of $4.76 billion, down 1.8% Y/Y (up 2.3% on a currency-neutral basis), slightly better than the consensus of $4.72 billion. Revenue was driven by base revenue growth of 4.2% as reported, 8.6% currency-neutral. Medical segment sales increased 5.8% Y/Y to $2.38 billion. Life Sciences segment sales declined 15.9% Y/Y to $1.29 billion, reflecting the decline in COVID-only testing revenues. Interventional segment revenues grew 2.4% Y/Y to